BNP Paribas Financial Markets
TDAC

BNP Paribas Financial Markets’s Translational Development Acquisition Corp TDAC Stock Holding History

BNP Paribas Financial Markets’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.7K Buy
+3,946
New +$41.6K ﹤0.01% 4789

Other funds holding TDAC

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

BNP Paribas Financial Markets's TDAC Position: Q1 2026 in Review

BNP Paribas Financial Markets opened a new position in Translational Development Acquisition Corp (TDAC) in Q1 2026: 3,946 shares worth $41.7K. The stake represents ﹤0.01% of the portfolio and ranks #4789 among its holdings.

48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • BNP Paribas Financial Markets held 3,946 shares of Translational Development Acquisition Corp worth $41.7K as of Q1 2026.
  • Translational Development Acquisition Corp was a new BNP Paribas Financial Markets position in Q1 2026.
  • Translational Development Acquisition Corp made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4789 holding.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.